Total Payments
$1,136
2024 Payments
$134.71
Companies
19
Transactions
53
Medicare Patients
10,414
Medicare Billing
$432,796
Payment Breakdown by Category
Food & Beverage$1,136 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,136 | 53 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $244.85 | 12 | $0 (2024) |
| Amgen Inc. | $136.42 | 7 | $0 (2023) |
| Lilly USA, LLC | $131.16 | 7 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $125.00 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $94.37 | 6 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $52.50 | 2 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $45.83 | 2 | $0 (2023) |
| GlaxoSmithKline, LLC. | $41.25 | 2 | $0 (2023) |
| PFIZER INC. | $40.78 | 2 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $36.63 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $134.71 | 7 | Novo Nordisk Inc ($36.07) |
| 2023 | $359.65 | 17 | Novo Nordisk Inc ($60.83) |
| 2022 | $167.37 | 9 | Amgen Inc. ($42.22) |
| 2019 | $208.90 | 12 | Novo Nordisk Inc ($79.92) |
| 2018 | $140.70 | 7 | Novo Nordisk Inc ($43.73) |
| 2017 | $125.00 | 1 | Merck Sharp & Dohme Corporation ($125.00) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Gastroenterology | ||||||
| 05/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/16/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: Diabetes | ||||||
| 04/24/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.36 | General |
| 02/08/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: PSYCHIATRY | ||||||
| 01/24/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Diabetes | ||||||
| 01/10/2024 | Hikma Pharmaceuticals USA | Ryaltris (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 12/06/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Oncology | ||||||
| 11/15/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Diabetes Care | ||||||
| 11/15/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Bone Health | ||||||
| 11/01/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Cardiology | ||||||
| 10/11/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Diabetes | ||||||
| 09/20/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Obesity | ||||||
| 09/11/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Diabetes | ||||||
| 08/31/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: PSYCHIATRY | ||||||
| 08/23/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/09/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: RESPIRATORY | ||||||
| 06/26/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: RESPIRATORY | ||||||
| 06/22/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $30.67 | General |
| Category: Cardio-renal | ||||||
| 05/17/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Diabetes | ||||||
| 03/29/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Bone Health | ||||||
| 03/15/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: INSOMNIA | ||||||
| 03/01/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: Diabetes | ||||||
| 02/01/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: DIABETES | ||||||
| 12/07/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 2,466 | 3,257 | $301,410 | $111,109 |
| 2022 | 33 | 2,547 | 3,275 | $301,731 | $106,408 |
| 2021 | 35 | 2,628 | 3,504 | $316,909 | $113,565 |
| 2020 | 37 | 2,773 | 3,561 | $318,028 | $101,714 |
Total Patients
10,414
Total Services
13,597
Medicare Billing
$432,796
Procedure Codes
136
All Medicare Procedures & Services
136 procedure records from CMS Medicare Utilization — Page 5 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 142 | 142 | $32,518 | $17,681 | 54.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 203 | 300 | $47,100 | $13,745 | 29.2% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 121 | 124 | $13,144 | $7,519 | 57.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 26 | 26 | $9,152 | $4,754 | 51.9% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 39 | 39 | $13,368 | $4,653 | 34.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2020 | 206 | 216 | $14,904 | $2,877 | 19.3% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2020 | 12 | 12 | $3,048 | $2,682 | 88.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2020 | 14 | 14 | $4,760 | $2,492 | 52.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 129 | 132 | $7,260 | $2,340 | 32.2% |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | Office | 2020 | 20 | 22 | $6,600 | $2,200 | 33.3% |
| 80048 | Blood test, basic group of blood chemicals | Office | 2020 | 165 | 252 | $11,088 | $2,118 | 19.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2020 | 180 | 192 | $10,560 | $2,018 | 19.1% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 125 | 210 | $10,500 | $2,018 | 19.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 30 | 32 | $5,629 | $1,937 | 34.4% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 69 | 75 | $7,050 | $1,925 | 27.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 301 | 576 | $11,520 | $1,715 | 14.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2020 | 85 | 95 | $8,170 | $1,585 | 19.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2020 | 136 | 172 | $6,880 | $1,328 | 19.3% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 27 | 29 | $2,668 | $1,047 | 39.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 82 | 88 | $6,336 | $936.39 | 14.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 51 | 51 | $2,805 | $902.73 | 32.2% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2020 | 46 | 46 | $2,392 | $883.97 | 37.0% |
| 84153 | Psa (prostate specific antigen) measurement | Office | 2020 | 30 | 31 | $2,914 | $568.61 | 19.5% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 23 | 25 | $1,075 | $461.15 | 42.9% |
| 82043 | Urine microalbumin (protein) level | Office | 2020 | 70 | 71 | $2,130 | $408.46 | 19.2% |
About Dr. Robert Hurst, MD
Dr. Robert Hurst, MD is a Internal Medicine healthcare provider based in Bloomingdale, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972579142.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Hurst, MD has received a total of $1,136 in payments from pharmaceutical and medical device companies, with $134.71 received in 2024. These payments were reported across 53 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,136).
As a Medicare-enrolled provider, Hurst has provided services to 10,414 Medicare beneficiaries, totaling 13,597 services with total Medicare billing of $432,796. Data is available for 4 years (2020–2023), covering 136 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Bloomingdale, IL
- Active Since 02/27/2006
- Last Updated 08/08/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1972579142
Products in Payments
- Ozempic (Drug) $168.67
- BRIDION (Drug) $125.00
- EVENITY (Biological) $97.43
- JARDIANCE (Drug) $83.76
- FARXIGA (Drug) $66.49
- MOUNJARO (Drug) $61.32
- REXULTI (Drug) $52.50
- Rybelsus (Drug) $44.01
- AREXVY (Drug) $41.25
- XARELTO (Drug) $36.63
- Kerendia (Drug) $30.67
- QUVIVIQ (Drug) $28.73
- Cologuard Collection Kit (Device) $24.96
- LANTUS (Drug) $21.94
- Repatha (Biological) $21.76
- VIAGRA (Drug) $21.73
- FREESTYLE LIBRE 3 (Device) $19.93
- CHANTIX (Drug) $19.05
- TRULICITY (Drug) $18.80
- Otezla (Drug) $17.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bloomingdale
Dr. Aziz Ahmed, M.d, M.D
Internal Medicine — Payments: $12,894
Internal Medicine $12,894
Vanja Cuk, Md, MD
Internal Medicine — Payments: $8,808
Internal Medicine $8,808
Dr. Sanjay Patel, M.d, M.D
Internal Medicine — Payments: $5,443
Internal Medicine $5,443
Dr. Mahrukh Subhani, M.d, M.D
Internal Medicine — Payments: $2,723
Internal Medicine $2,723
Sonal Patel, Do, DO
Internal Medicine — Payments: $753.69
Internal Medicine $753.69
Wahaj Ahmed, M.d, M.D
Internal Medicine — Payments: $670.83
Internal Medicine $670.83